Back to HALO
GW&K Investment Management, LLC → HALO
GW&K Investment Management, LLC HALO Position History
Halozyme Therapeutics, Inc. • Healthcare
Quarters held
10
Latest value
$7.5M
Q3 2026
Peak value
$118.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $85.9M |
| Q3 2025 | $6.6M |
| Q4 2025 | $78.5M |
| Q4 2025 | $5.9M |
| Q1 2026 | $84.4M |
| Q1 2026 | $5.7M |
| Q2 2026 | $99.2M |
| Q2 2026 | $6.7M |
| Q3 2026 | $118.4M |
| Q3 2026 | $7.5M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $7.5M | 68.0K | — | — |
| Q3 2026 | $118.4M | 1.07M | — | — |
| Q2 2026 | $6.7M | 86.1K | — | — |
| Q2 2026 | $99.2M | 1.27M | — | — |
| Q1 2026 | $5.7M | 88.3K | — | — |
| Q1 2026 | $84.4M | 1.31M | — | — |
| Q4 2025 | $5.9M | 87.7K | — | — |
| Q4 2025 | $78.5M | 1.17M | — | — |
| Q3 2025 | $6.6M | 90.6K | — | — |
| Q3 2025 | $85.9M | 1.17M | — | — |
Other funds holding HALO
$915.4M
$649.5M
$559M
$545.3M
$539.3M
$531.8M